S. Barbey

发表

Malignant histiocytosis in childhood: a distinctive CD30-positive clinicopathological entity associated with a chromosomal translocation involving 5q35.

J. Gogusev, M. Terrier-Lacombe, C. Nezelof, 1992, Seminars in diagnostic pathology.

Genotype markers and proto‐oncogene analysis in the cd30‐positive “malignant histiocytosis” del cell line with t(5;6)(q35;p21)

J. Gogusev, C. Nezelof, S. Barbey, 1990, International journal of cancer.

PML protein expression in hematopoietic and acute promyelocytic leukemia cells.

H. de Thé, A. Bazarbachi, M. Koken, 1993, Blood.

Human malignant histiocytosis CD30+ DEL cell line differentiates into macrophage-like cells when treated with a phorbol diester.

J. Gogusev, C. Nezelof, S. Barbey, 1991, Cancer research.

Histiocytosis X Langerhans cells react with antiinterleukin-2 receptor monoclonal antibody.

P. Gane, C. Nezelof, S. Barbey, 1987, Pediatric pathology.

In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells.

P. Fenaux, C. Chomienne, L. Degos, 1995, Leukemia.

Reactivity of histiocytosis X cells with monoclonal antibodies.

L. Chatenoud, F. Jaubert, C. Nezelof, 1983, Pathology, research and practice.

Histiocytosis: nosology and pathobiology.

C. Nezelof, S. Barbey, Sylvette Barbey, 1985, Pediatric pathology.

Metelation of diazines VIII metalation of 4-chloropyrimidine derivatives new synthesis of trimethoprim

S. Barbey, A. Turck, N. Plé, 1993 .

Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor.

Valérie Choesmel, Catherine Michaux, T. Taverne, 2002, Bioorganic & medicinal chemistry letters.

A Novel Approach to the Skeletons of the Ergot Alkaloids and Secoergolines

J. Mann, S. Barbey, 1995 .

PML protein expression in hematopoietic and acute promyelocytic leukemia cells.

H. de Thé, A. Bazarbachi, M. Koken, 1993, Blood.

Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.

M. Kornprobst, F. Arenzana‐Seisdedos, J. Virelizier, 1986, The Journal of clinical investigation.

Histiocyte X positivity for nonspecific esterase.

F. Jaubert, C. Nezelof, S. Barbey, 1980, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Histiocytes X and X body reactivity with concanavalin A, peanut agglutinin and BSPT.

P. Gane, F. Jaubert, C. Nezelof, 1987, Pathology, research and practice.

[Histocytosis-X. Histochemical and autoradiographic elements proving lipid synthesis in in vitro culture].

C. Nezelof, S. Barbey, M. F. Rousseau, 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

45. Regulation of BcI-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemic cells

L. Sachs, L. Degos, S. Barbey, 1992 .

Collagenolytic activity of eosinophilic granuloma in vitro

C. Nezelof, S. Barbey, M. Rousseau-Merck, 1979, Experientia.

Rapid Publication Histiocytosis X Purified (T6+) Cells from Bone Granuloma Produce Interleukin I and Prostaglandin E2 in Culture

M. Kornprobst, F. Arenzana‐Seisdedos, J. Virelizier, 2022 .

Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.

J. Gogusev, C. Nezelof, S. Barbey, 1993, Anticancer Research.

Failure of histiocytosis X cells to express i blood group antigen.

P. Gane, C. Nezelof, S. Barbey, 1985, Pathology, research and practice.